Excelsior Medical Co., Ltd.(TW:4104)
NT$72.00-0.10 (-0.14%)
TW:4104
Excelsior Medical Co., Ltd. financials statements
NT$72.00
At close:-0.10 (-0.14%)
Excelsior Medical Co., Ltd. (4104) Income Statement
Excelsior Medical Co., Ltd. Income Statement
Last quarter (Q2 2026), Excelsior Medical Co., Ltd.'s total revenue was NT$2.39B, an increase of 10.21% from the same quarter last year. In Q2, Excelsior Medical Co., Ltd.'s net income was NT$308.50M. See Excelsior Medical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 8.79B | NT$ 8.54B | NT$ 8.23B | NT$ 7.19B | NT$ 6.57B | |
| NT$ 1.87B | NT$ 1.78B | NT$ 1.67B | NT$ 1.51B | NT$ 1.37B | |
| NT$ 1.06B | NT$ 1.03B | NT$ 919.21M | NT$ 893.28M | NT$ 770.54M | |
| Depreciation and Amortization | NT$ 301.38M | NT$ 300.83M | NT$ 265.68M | NT$ 222.44M | NT$ 202.95M |
| NT$ 1.04B | NT$ 1.18B | NT$ 968.56M | NT$ 1.20B | NT$ 1.09B | |
| NT$ 739.84M | NT$ 749.67M | NT$ 702.88M | NT$ 869.86M | NT$ 769.23M | |
| NT$ 442.06M | NT$ 421.05M | NT$ 441.20M | NT$ 93.84M | NT$ 104.50M | |
| NT$ 1.18B | NT$ 1.17B | NT$ 1.14B | NT$ 963.70M | NT$ 873.74M | |
| NT$ 805.86M | NT$ 771.26M | NT$ 746.61M | NT$ 667.45M | NT$ 607.15M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 4.62 | NT$ 4.48 | NT$ 4.57 | NT$ 4.08 | NT$ 3.71 |
| Diluted EPS | NT$ 4.62 | NT$ 4.48 | NT$ 4.55 | NT$ 4.07 | NT$ 3.69 |
| Weighted Average Shares Outstanding | 208.90M | 171.57M | 163.40M | 163.40M | 163.40M |
| Weighted Average Shares Outstanding (Diluted) | 208.90M | 172.26M | 164.08M | 164.23M | 164.32M |
Currency in TWD
